Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARA | P10276 | 4/20 | 0.46 |
| ▸ | RARG | P13631 | 4/20 | 0.46 |
| ▸ | RARB | P10826 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.36 |
| ▸ | CPT1B | Q92523 | 1/20 | 0.34 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | MAOB | P27338 | 1/20 | 0.33 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.33 |
| ▸ | WNT3A | P56704 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8629848 | 0.73 | RARG (0.85) | RARARARGRARB | |
| SCHEMBL8404565 | 0.73 | MMP12 (0.40) | RARARARGRARBALDH1A1ALOX5 | |
| SCHEMBL8901628 | 0.70 | RARA (0.52) | RARARARGRARBALDH1A1MAPK1 | |
| SCHEMBL6621631 | 0.68 | TSHR (0.65) | ALDH1A1MAPK1MEN1KMT2AKDM4E | |
| SCHEMBL11491646 | 0.68 | ALDH1A1 (0.72) | ALDH1A1MAPK1MEN1KMT2ASRD5A2 | |
| SCHEMBL38655970 | 0.68 | ALDH1A1 (0.72) | ALDH1A1MAPK1MEN1KMT2ASRD5A2 | |
| SCHEMBL24215392 | 0.67 | PTGS2 (0.32) | ALOX5 | |
| SCHEMBL20839732 | 0.66 | CA12 (0.48) | RARARARGRARBALDH1A1MEN1 | |
| SCHEMBL294210 | 0.65 | ALOX5 (0.49) | ALDH1A1MAPK1MEN1KMT2AALOX5 | |
| SCHEMBL11320077 | 0.65 | CPT1B (0.38) | ALDH1A1MAPK1MEN1KMT2ASRD5A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10744213-B2 | Fluorescent compounds for imaging of blood vessels and blood flow, and an in vivo screen for pro- and anti-angiogenic agents | COLOSSUS BIOPHARMA CONSULTANTS COMPANY, LIMITED (TW) | 2020-08-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10744213-B2 | Fluorescent compounds for imaging of blood vessels and blood flow, and an in vivo screen for pro- and anti-angiogenic agents | FLT4, VEGFA, FLT1 | RARA 1680/4885RARG 1290/4885RARB 1161/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.